Celltheon has been developing Cell Engineering technologies since 2012. Celltheon has patents, granted and pending, for its CHOK-1 derived SUPERCELL™ cell line and its unique DNA and RNA vector elements that are applicable for recombinant biotherapeutics such as Mabs, Difficult to Express Proteins (DEP) as well as for CAR-T, Gene Therapy, and Cell Factories applications.

Biotechnology

Celltheon

Celltheon's headquarters in Union City, CA, United States

Description

People (1)

Nikhil Goel

Jobs